A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology

Abstract Artificial intelligence technology has advanced rapidly in recent years and has the potential to improve healthcare outcomes. However, technology uptake will be largely driven by clinicians, and there is a paucity of data regarding the attitude that clinicians have to this new technology. I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jane Scheetz, Philip Rothschild, Myra McGuinness, Xavier Hadoux, H. Peter Soyer, Monika Janda, James J.J. Condon, Luke Oakden-Rayner, Lyle J. Palmer, Stuart Keel, Peter van Wijngaarden
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c0dd39a13e2049d68ce2c943b58bb2f8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c0dd39a13e2049d68ce2c943b58bb2f8
record_format dspace
spelling oai:doaj.org-article:c0dd39a13e2049d68ce2c943b58bb2f82021-12-02T13:35:03ZA survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology10.1038/s41598-021-84698-52045-2322https://doaj.org/article/c0dd39a13e2049d68ce2c943b58bb2f82021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84698-5https://doaj.org/toc/2045-2322Abstract Artificial intelligence technology has advanced rapidly in recent years and has the potential to improve healthcare outcomes. However, technology uptake will be largely driven by clinicians, and there is a paucity of data regarding the attitude that clinicians have to this new technology. In June–August 2019 we conducted an online survey of fellows and trainees of three specialty colleges (ophthalmology, radiology/radiation oncology, dermatology) in Australia and New Zealand on artificial intelligence. There were 632 complete responses (n = 305, 230, and 97, respectively), equating to a response rate of 20.4%, 5.1%, and 13.2% for the above colleges, respectively. The majority (n = 449, 71.0%) believed artificial intelligence would improve their field of medicine, and that medical workforce needs would be impacted by the technology within the next decade (n = 542, 85.8%). Improved disease screening and streamlining of monotonous tasks were identified as key benefits of artificial intelligence. The divestment of healthcare to technology companies and medical liability implications were the greatest concerns. Education was identified as a priority to prepare clinicians for the implementation of artificial intelligence in healthcare. This survey highlights parallels between the perceptions of different clinician groups in Australia and New Zealand about artificial intelligence in medicine. Artificial intelligence was recognized as valuable technology that will have wide-ranging impacts on healthcare.Jane ScheetzPhilip RothschildMyra McGuinnessXavier HadouxH. Peter SoyerMonika JandaJames J.J. CondonLuke Oakden-RaynerLyle J. PalmerStuart KeelPeter van WijngaardenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jane Scheetz
Philip Rothschild
Myra McGuinness
Xavier Hadoux
H. Peter Soyer
Monika Janda
James J.J. Condon
Luke Oakden-Rayner
Lyle J. Palmer
Stuart Keel
Peter van Wijngaarden
A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
description Abstract Artificial intelligence technology has advanced rapidly in recent years and has the potential to improve healthcare outcomes. However, technology uptake will be largely driven by clinicians, and there is a paucity of data regarding the attitude that clinicians have to this new technology. In June–August 2019 we conducted an online survey of fellows and trainees of three specialty colleges (ophthalmology, radiology/radiation oncology, dermatology) in Australia and New Zealand on artificial intelligence. There were 632 complete responses (n = 305, 230, and 97, respectively), equating to a response rate of 20.4%, 5.1%, and 13.2% for the above colleges, respectively. The majority (n = 449, 71.0%) believed artificial intelligence would improve their field of medicine, and that medical workforce needs would be impacted by the technology within the next decade (n = 542, 85.8%). Improved disease screening and streamlining of monotonous tasks were identified as key benefits of artificial intelligence. The divestment of healthcare to technology companies and medical liability implications were the greatest concerns. Education was identified as a priority to prepare clinicians for the implementation of artificial intelligence in healthcare. This survey highlights parallels between the perceptions of different clinician groups in Australia and New Zealand about artificial intelligence in medicine. Artificial intelligence was recognized as valuable technology that will have wide-ranging impacts on healthcare.
format article
author Jane Scheetz
Philip Rothschild
Myra McGuinness
Xavier Hadoux
H. Peter Soyer
Monika Janda
James J.J. Condon
Luke Oakden-Rayner
Lyle J. Palmer
Stuart Keel
Peter van Wijngaarden
author_facet Jane Scheetz
Philip Rothschild
Myra McGuinness
Xavier Hadoux
H. Peter Soyer
Monika Janda
James J.J. Condon
Luke Oakden-Rayner
Lyle J. Palmer
Stuart Keel
Peter van Wijngaarden
author_sort Jane Scheetz
title A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
title_short A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
title_full A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
title_fullStr A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
title_full_unstemmed A survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
title_sort survey of clinicians on the use of artificial intelligence in ophthalmology, dermatology, radiology and radiation oncology
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c0dd39a13e2049d68ce2c943b58bb2f8
work_keys_str_mv AT janescheetz asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT philiprothschild asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT myramcguinness asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT xavierhadoux asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT hpetersoyer asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT monikajanda asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT jamesjjcondon asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT lukeoakdenrayner asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT lylejpalmer asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT stuartkeel asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT petervanwijngaarden asurveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT janescheetz surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT philiprothschild surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT myramcguinness surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT xavierhadoux surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT hpetersoyer surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT monikajanda surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT jamesjjcondon surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT lukeoakdenrayner surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT lylejpalmer surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT stuartkeel surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
AT petervanwijngaarden surveyofcliniciansontheuseofartificialintelligenceinophthalmologydermatologyradiologyandradiationoncology
_version_ 1718392698459652096